Walnut oligopeptide improves cognitive performance and sleep quality among teenagers and elderly people.
In this randomized double-blind placebo-controlled clinical trial, 36 individuals (comprised of teenagers and elderly people) were divided into groups and given either a placebo or walnut oligopeptide (WO) at low or high dosages. The division was random and the dosage groups were composed of 6 individuals from each population group (teenagers and elderly). The administration of either substance was over a period of 90 days.
The results showed notable improvements in subjects who were administered WO. Test scores on the Wechsler Adult Intelligence Scale (WAIS) showed a significant increase, indicating an improvement in cognitive ability. In addition, there was a decrease in the scores on the global Pittsburgh Sleep Quality Index (PSQI), suggesting an improvement in the quality of sleep among the subjects. Furthermore, average scores in Chinese, Mathematics, and English were significantly improved from the baseline scores among the teenagers in the WO administered group. Thus, these findings support the potential use of WO in nutritional intervention to boost memory, cognitive ability, and sleep quality in teenagers and elderly people.